Yiting Tang
Impact in
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
- Immunology top 5%
- Immune Response and Inflammation
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- interferon and immune responses
Papers in
-
- Inflammasome and immune disorders 25
- Heme Oxygenase-1 and Carbon Monoxide 5
- Immunology 25
- Immune Response and Inflammation 15
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 7
- Inflammation biomarkers and pathways 4
- Co-authors
- Ben Lü (20 shared papers)Haichao Wang (13 shared papers)Xianzhong Xiao (12 shared papers)Timothy R. Billiar (11 shared papers)Jan Andersson (4 shared papers)Kevin J. Tracey (3 shared papers)Kai Zhao (13 shared papers)Xinyu Yang (6 shared papers)
- Journals
- Shock (4 papers)Molecular Medicine (4 papers)International Immunopharmacology (3 papers)Frontiers in Immunology (2 papers)Immunity (2 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Yiting Tang
50 papers receiving 2.1k citations
Yiting Tang's Hit Papers
Peers
Comparison fields: 5 of 107
- Clinical Biochemistry 336
- Immunology 787
- Nephrology 149
- Biological Psychiatry 45
- Molecular Biology 1.2k
Countries citing papers authored by Yiting Tang
This map shows the geographic impact of Yiting Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiting Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiting Tang more than expected).
Fields of papers citing papers by Yiting Tang
This network shows the impact of papers produced by Yiting Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiting Tang. The network helps show where Yiting Tang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yiting Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Novel role of PKR in inflammasome activation and HMGB1 release Hit paper breakdown → | 2012 | 632 |
| 2 | 2019 | 235 | |
| 3 | 2015 | 110 | |
| 4 | 2021 | 99 | |
| 5 | 2022 | 91 | |
| 6 | 2009 | 69 | |
| 7 | 2020 | 62 | |
| 8 | 2019 | 54 | |
| 9 | 2018 | 52 | |
| 10 | 2009 | 46 | |
| 11 | 2018 | 42 | |
| 12 | 2015 | 38 | |
| 13 | 2020 | 36 | |
| 14 | 2020 | 33 | |
| 15 | 2007 | 32 | |
| 16 | 2020 | 29 | |
| 17 | 2017 | 28 | |
| 18 | 2018 | 27 | |
| 19 | 2008 | 27 | |
| 20 | 2010 | 27 |
About Yiting Tang
Yiting Tang is a scholar working on Molecular Biology, Immunology, Pulmonary and Respiratory Medicine, Clinical Biochemistry and Epidemiology, having authored 50 papers that have together received 2.1k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (25 papers), Immune Response and Inflammation (15 papers), Advanced Glycation End Products research (9 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Heme Oxygenase-1 and Carbon Monoxide (5 papers), MicroRNA in disease regulation (4 papers) and Inflammation biomarkers and pathways (4 papers). The work is most often cited by research in Clinical Biochemistry (336 citations), Immunology (787 citations), Nephrology (149 citations), Biological Psychiatry (45 citations) and Molecular Biology (1.2k citations). Yiting Tang has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Ben Lü, Haichao Wang, Xianzhong Xiao, Timothy R. Billiar, Jan Andersson, Kevin J. Tracey, Kai Zhao, Xinyu Yang, Sangeeta S. Chavan and Jianhua Li. Their work appears in journals such as Shock, Molecular Medicine, International Immunopharmacology, Frontiers in Immunology and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.